PharmaCyte Biotech, Inc. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2012 to 2023.
  • PharmaCyte Biotech, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending July 31, 2024 was $23.4M.
  • PharmaCyte Biotech, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending July 31, 2024 was $26.9M.
  • PharmaCyte Biotech, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $333K.
  • PharmaCyte Biotech, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$4.32M, a 2.1% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$4.23M, a 19.3% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $333K +$4.66M May 1, 2023 Apr 30, 2024 10-K 2024-08-13
2022 -$4.32M -$88.7K -2.1% May 1, 2022 Apr 30, 2023 10-K 2024-08-13
2021 -$4.23M -$685K -19.3% May 1, 2021 Apr 30, 2022 10-K 2023-07-31
2020 -$3.55M +$285K +7.43% May 1, 2020 Apr 30, 2021 10-K 2022-07-28
2019 -$3.83M +$242K +5.93% May 1, 2019 Apr 30, 2020 10-K 2021-08-10
2018 -$4.08M +$2.76M +40.4% May 1, 2018 Apr 30, 2019 10-K 2020-08-13
2017 -$6.84M -$2.39M -53.9% May 1, 2017 Apr 30, 2018 10-K 2019-08-13
2016 -$4.44M +$1.62M +26.7% May 1, 2016 Apr 30, 2017 10-K 2018-07-20
2015 -$6.06M +$3.86M +38.9% May 1, 2015 Apr 30, 2016 10-K 2017-07-27
2014 -$9.93M +$17.3M +63.6% May 1, 2014 Apr 30, 2015 10-K 2016-07-29
2013 -$27.3M -$25.7M -1605% May 1, 2013 Apr 30, 2014 10-K 2016-07-29
2012 -$1.6M May 1, 2012 Apr 30, 2013 10-K/A 2016-01-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.